Access cutting-edge nasal polyps treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access nasal polyps specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related nasal polyps treatment provided free
The main objective of this study is to evaluate treatment outcomes of tezepelumab among participants with physician-determined surgery-eligible CRSwNP, with or without asthma. Study details include: 1. The study duration will be up to 40 weeks. 2. The treatment duration will be up to 24 weeks. 3. The visit frequency will be once every 4 weeks (Q4W).
Sponsor: AstraZeneca
Check if you qualify for this nasal polyps clinical trial in Chicago, IL
If you're searching for nasal polyps treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nasal polyps specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.